Lexston Life Sciences Corp.'s total assets for Q2 2024 were $576.16K, a decrease of -19.11% from the previous quarter. TSE:LEXT total liabilities were $22.16K for the fiscal quarter, a 2.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.